Skip to Main Content

Paper Details

The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders.
Cell
78
2018
Neuropsychiatric Disorders, Tourette disorder, autism spectrum disorder, cancer, congenital heart defects, epilepsy, genes, infectious disease, intellectual disability, neuropsychiatric disorders, schizophrenia
Chromosome Mapping, Gene Regulatory Networks, Genetic Predisposition to Disease, Genome-Wide Association Study, Genomics, Humans, Neurobiology, Neurodevelopmental Disorders, Neuropsychiatry, Systems Biology
Author NameAffiliation
Arthur Jeremy WillseyUCSF Weill Institute for Neurosciences, University of California, USA Institute for Neurodegenerative Diseases, USA Quantitative Biosciences Institute (QBI) san francisco
Arthur Jeremy WillseyUCSF Weill Institute for Neurosciences, University of California, USA Institute for Neurodegenerative Diseases, USA Quantitative Biosciences Institute (QBI) san francisco
Montana T MorrisInstitute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California san francisco
Sheng WangInstitute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California san francisco
Helen Rankin WillseyUCSF Weill Institute for Neurosciences, University of California san francisco
Nawei SunInstitute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California san francisco
Nia TeerikorpiInstitute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California san francisco
Tierney BaumInstitute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California san francisco
Gerard CagneyConway Institute, University College Dublin
Kevin J BenderUCSF Weill Institute for Neurosciences, University of California san francisco
Tejal A DesaiQuantitative Biosciences Institute (QBI), University of California san francisco
Deepak SrivastavaGladstone Institutes, University of California san francisco
Deepak SrivastavaGladstone Institutes, University of California san francisco
Graeme W DavisUniversity of California, USA Kavli Institute for Fundamental Neuroscience san francisco
Jennifer A DoudnaUniversity of California, USA Howard Hughes Medical Institute, USA Innovative Genomics Institute, Lawrence Berkeley National Laboratory
Edward F ChangUCSF Weill Institute for Neurosciences, University of California san francisco
Vikaas S SohalUCSF Weill Institute for Neurosciences, University of California, USA Kavli Institute for Fundamental Neuroscience san francisco
Daniel H LowensteinUCSF Weill Institute for Neurosciences, University of California san francisco
Hao LiQuantitative Biosciences Institute (QBI), University of California san francisco
David A AgardQuantitative Biosciences Institute (QBI), University of California san francisco
Michael J KeiserInstitute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California, USA Quantitative Biosciences Institute (QBI), USA Department of Pharmaceutical Chemistry san francisco
Brian K ShoichetQuantitative Biosciences Institute (QBI), University of California, USA Department of Pharmaceutical Chemistry san francisco
Brian K ShoichetQuantitative Biosciences Institute (QBI), University of California, USA Department of Pharmaceutical Chemistry san francisco
Mark von ZastrowUCSF Weill Institute for Neurosciences, University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Lennart MuckeUCSF Weill Institute for Neurosciences, University of California, USA Gladstone Institutes san francisco
Steven FinkbeinerUCSF Weill Institute for Neurosciences, University of California, USA Gladstone Institutes san francisco
Steven FinkbeinerUCSF Weill Institute for Neurosciences, University of California, USA Gladstone Institutes san francisco
Li GanUCSF Weill Institute for Neurosciences, University of California, USA Gladstone Institutes san francisco
Nenad SestanDepartment of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine
Nenad SestanDepartment of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine
Michael E WardNational Institute of Neurological Disorders and Stroke
Ruth H??ttenhainQuantitative Biosciences Institute (QBI), University of California, USA Gladstone Institutes san francisco
Ruth H??ttenhainQuantitative Biosciences Institute (QBI), University of California, USA Gladstone Institutes san francisco
Tomasz J NowakowskiUCSF Weill Institute for Neurosciences, University of California san francisco
Hugo J BellenNeurological Research Institute at TCH, Baylor College of Medicine, USA Howard Hughes Medical Institute
Hugo J BellenNeurological Research Institute at TCH, Baylor College of Medicine, USA Howard Hughes Medical Institute
Loren M FrankKavli Institute for Fundamental Neuroscience, University of California, USA Howard Hughes Medical Institute san francisco
Mustafa K KhokhaYale University School of Medicine
Richard P LiftonThe Rockefeller University
Richard P LiftonThe Rockefeller University
Martin KampmannInstitute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Trey Ideker (CM4AI)University of California
Trey Ideker (CM4AI)University of California
Matthew W StateUCSF Weill Institute for Neurosciences, University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Matthew W StateUCSF Weill Institute for Neurosciences, University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Nevan J Krogan (CM4AI)Quantitative Biosciences Institute (QBI), University of California, USA Gladstone Institutes, USA Helen Diller Comprehensive Cancer Center san francisco
  • 1 - 46

Datasets